3 June 2021COMPASS Pathways (CMPS.Q) reports results from COMP360 study on cognitive…Piers Eaton CMPS.Q COMPASS Pathways (CMPS.Q) reported further results from a Phase I study on their COMP360 psilocybin conducted at King’s College London. The study was a randomized, double-blind, placebo-controlled study intended…